Cargando...
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
PURPOSE: Pegaptanib has been shown to be effective in treating diabetic macular edema (DME). In the original Phase II/III trial, however, patients with macular ischemia were excluded. In this study, we treated patients with ischemic DME. METHODS: Macular ischemia was defined as a 30% increase in the...
Gardado en:
| Publicado en: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4686329/ https://ncbi.nlm.nih.gov/pubmed/26715833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S90322 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|